The Clinical Core of the Emory Alzheimer's Disease Center (ADC) provides state-of-the-art diagnostic assessment of AD and other dementias, with a special emphasis on comorbid conditions that contribute to impaired cognition. The primary mission of the Core is to afford access to well-characterized patient pools with which to conduct innovative clinical and basic research projects. The Emory ADC has many unique features, including a large, ethnically diverse patient population and investigators with expertise in clinical and basic science related to a broad range of dementing illnesses. In addition, there is active involvement of established investigators with expertise in other conditions known to impair cognition in the aged population. An implicit component of the Clinical Core is the broadening notion of Mild Cognitive Impairment (MCI). A major challenge is to identify features that will predict which cases of MCI will progress to AD, or other dementing disorders, including dementia with Lewy bodies, vascular dementia, and Parkinson's disease. In addition, a substantial body of literature indicates that conditions, such as depression, cardiac disease, diabetes, hypertension, and sleep apnea, which are highly prevalent in the geriatric population, exert strong independent influences on cognitive function, and they can accelerate the progression of degenerative neurologic diseases. Through the activities of the Clinical Core and its interactions with other components of the Emory ADC, we will achieve three specific aims: 1) to evaluate cases of MCI, AD, and other dementias by systematic collection and evaluation of neurological and neuropsychological measures and examination of medical comorbidities; 2) to enhance the care of patients and families through comprehensive clinical services, education, and access to promising clinical trials and other research activities; and 3) to support and promote research studies by sharing carefully and systematically collected data from registry participants, including clinical evaluations, family histories, DMA, and other biological materials.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG025688-04
Application #
7618211
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
4
Fiscal Year
2008
Total Cost
$514,131
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Jucker, Mathias; Walker, Lary C (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 21:1341-1349
Rangaraju, Srikant; Dammer, Eric B; Raza, Syed Ali et al. (2018) Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Mol Neurodegener 13:24
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Cherry, Jonathan D; Zeineddin, Ahmad; Dammer, Eric B et al. (2018) Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol 77:40-49
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 444 publications